News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
667,731 Results
Type
Article (33891)
Company Profile (179)
Press Release (633652)
Multimedia
Podcasts (55)
Webinars (12)
Section
Business (211349)
Career Advice (811)
Deals (31584)
Drug Delivery (78)
Drug Development (73305)
Employer Resources (63)
FDA (15406)
Job Trends (13040)
News (313707)
Policy (29170)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (2135)
Accelerated approval (42)
ADA (40)
Adcomms (13)
Allergies (187)
Alliances (44591)
ALS (189)
Alzheimer's disease (1681)
Antibody-drug conjugate (ADC) (426)
Approvals (16150)
Artificial intelligence (600)
ASCO (272)
Autoimmune disease (322)
Automation (39)
Bankruptcy (320)
Best Places to Work (10341)
BIO (55)
Biologics (2)
BIOSECURE Act (6)
Biosimilars (175)
BioSpace Insights (87)
Biotechnology (112)
Bladder cancer (205)
Brain cancer (68)
Breast cancer (752)
Cancer (5744)
Cardiovascular disease (429)
Career advice (711)
Career pathing (29)
CAR-T (283)
CDC (36)
Celiac Disease (3)
Cell therapy (756)
Cervical cancer (56)
Clinical research (65774)
Collaboration (1897)
Commercialization (7)
Company closure (2)
Compensation (1544)
Complete response letters (55)
COVID-19 (1941)
CRISPR (92)
C-suite (1186)
Cystic fibrosis (128)
Data (8269)
Decentralized trials (2)
Denatured (33)
Depression (162)
Dermatology (107)
Diabetes (586)
Diagnostics (6081)
Digital health (60)
Diversity (9)
Diversity, equity & inclusion (19)
Drug discovery (266)
Drug pricing (159)
Drug shortages (24)
Duchenne muscular dystrophy (247)
Earnings (84830)
Editorial (44)
Employer branding (8)
Employer resources (60)
Events (111158)
Executive appointments (1060)
FDA (19505)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (23)
Frontotemporal dementia (29)
Funding (1526)
Gene editing (182)
Generative AI (39)
Gene therapy (549)
GLP-1 (783)
Government (3657)
Grass and pollen (4)
Guidances (395)
Healthcare (17037)
Hematology (158)
HIV (80)
Huntington's disease (45)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (96)
Immunology and inflammation (174)
Immuno-oncology (87)
Indications (223)
Infectious disease (2241)
Inflammatory bowel disease (204)
Inflation Reduction Act (13)
Influenza (119)
Intellectual property (301)
Interviews (101)
IPO (14725)
IRA (43)
Job creations (3085)
Job search strategy (630)
JPM (21)
Kidney cancer (23)
Labor market (58)
Layoffs (253)
Leadership (20)
Legal (7185)
Licensing (10)
Liver cancer (86)
Longevity (28)
Lung cancer (809)
Lymphoma (440)
Machine learning (43)
Management (22)
Manufacturing (828)
Marketing (11)
MASH (175)
Medical affairs (1)
Medical device (14467)
Medtech (14702)
Mergers & acquisitions (18161)
Metabolic disorders (1323)
mRNA (140)
Multiple sclerosis (176)
NASH (12)
Neurodegenerative disease (373)
Neuropsychiatric disorders (82)
Neuroscience (3105)
NextGen: Class of 2026 (5619)
Non-profit (3523)
Now hiring (49)
Obesity (522)
Opinion (185)
Ovarian cancer (225)
Pain (265)
Pancreatic cancer (306)
Parkinson's disease (333)
Partnered (30)
Patents (590)
Patient recruitment (808)
Peanut (61)
People (55827)
Pharmaceutical (40)
Pharmacy benefit managers (25)
Phase 1 (20427)
Phase 2 (28876)
Phase 3 (21292)
Pipeline (10159)
Policy (194)
Postmarket research (2403)
Preclinical (8327)
Press Release (47)
Prostate cancer (318)
Psychedelics (37)
Radiopharmaceuticals (313)
Rare diseases (954)
Real estate (4753)
Recruiting (24)
Regulatory (23715)
Reports (35)
Research institute (2057)
Resumes & cover letters (104)
Rett syndrome (47)
RNA editing (15)
RSV (71)
Schizophrenia (171)
Series A (246)
Series B (194)
Service/supplier (6)
Sickle cell disease (102)
Special edition (9)
Spinal muscular atrophy (146)
Sponsored (24)
Startups (3139)
Stomach cancer (14)
Supply chain (94)
Tariffs (41)
The Weekly (22)
Vaccines (792)
Venture capital (58)
Weight loss (322)
Women's health (129)
Worklife (6)
Date
Today (67)
Last 7 days (344)
Last 30 days (2129)
Last 365 days (26507)
2026 (17313)
2025 (26517)
2024 (31123)
2023 (35519)
2022 (46100)
2021 (49944)
2020 (48110)
2019 (39746)
2018 (29963)
2017 (27916)
2016 (27514)
2015 (33890)
2014 (28886)
2013 (24603)
2012 (26887)
2011 (27207)
2010 (26245)
Location
Africa (542)
Alabama (89)
Alaska (4)
Arizona (385)
Arkansas (16)
Asia (34399)
Australia (5281)
California (13909)
Canada (3758)
China (1349)
Colorado (623)
Connecticut (575)
Delaware (403)
Europe (65665)
Florida (2108)
Georgia (453)
Hawaii (3)
Idaho (58)
Illinois (1159)
India (81)
Indiana (562)
Iowa (19)
Japan (581)
Kansas (129)
Kentucky (42)
Louisiana (55)
Maine (34)
Maryland (1670)
Massachusetts (9569)
Michigan (380)
Minnesota (772)
Mississippi (7)
Missouri (137)
Montana (28)
Nebraska (26)
Nevada (142)
New Hampshire (80)
New Jersey (3615)
New Mexico (23)
New York (3561)
North Carolina (1737)
North Dakota (7)
Northern California (7017)
Ohio (383)
Oklahoma (20)
Oregon (37)
Pennsylvania (2669)
Puerto Rico (28)
Rhode Island (49)
South America (793)
South Carolina (86)
South Dakota (1)
Southern California (5660)
Tennessee (232)
Texas (2305)
United States (48386)
Utah (419)
Vermont (2)
Virginia (302)
Washington D.C. (72)
Washington State (1122)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
667,731 Results for "shape memory medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Shape Memory Medical Secures $10 Million Financing Led by August Global Partners to Advance Aortic Clinical Programs
August 23, 2026
·
5 min read
Press Releases
Study Reveals How Brain Remodeling During Adolescence Shapes Memory
July 19, 2026
·
6 min read
Press Releases
Scientists Turn COVID-19 Immune Memory into a Powerful New Ally Against Cancer
Nature Communications Publishes Breakthrough Study Showing How COVID-Era Immune Memory Can Be Redirected to Fight Cancer Celloram, Inc., University Hospitals, and Case Western Reserve University unveil PROTEXI, a novel cancer vaccine platform advancing toward first-in-human clinical trials in sarcoma patients.
July 27, 2026
·
1 min read
Biotech Bay
Shape Memory Medical Completes $38 Million in Financing to Advance Endovascular Embolization
Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced today that it has completed $38 million in Series C financing.
March 4, 2024
·
4 min read
Biotech Bay
Shape Memory Medical Announces First Patient Treated in the AAA-SHAPE Randomized Controlled Pivotal Trial
Shape Memory Medical Inc. announced the first patient treated as part of the AAA-SHAPE Pivotal Trial, the Company’s prospective, multicenter, randomized, open-label trial to determine safety and effectiveness of the IMPEDE-FX RapidFill® Device to improve abdominal aortic aneurysm (AAA) sac behavior when used with elective endovascular aneurysm repair (EVAR).
June 3, 2024
·
3 min read
Press Releases
Shape Memory Medical Announces European Enrollment in the AAA-SHAPE Randomized Controlled Pivotal Trial
February 20, 2025
·
3 min read
Press Releases
Shape Therapeutics and Rett Syndrome Research Trust Announce Partnership to Advance a One-Time AI-Designed RNA Editing Therapy for Rett Syndrome
August 6, 2026
·
4 min read
IN PARTNERSHIP WITH AGC BIOLOGICS
From ex vivo to in vivo: Shaping the next generation of viral vector manufacturing
The shift from ex vivo to in vivo gene delivery is rewriting the rules of viral vector manufacturing, forcing developers to rethink scale, purity, cell lines and analytics as vectors themselves become the drug. AGC Biologics is betting on stable producer lines, next‑gen purification and deeper characterization to meet the far stricter demands of in vivo therapies.
August 10, 2026
·
8 min read
·
Jennifer C. Smith-Parker
Press Releases
Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping
August 11, 2026
·
10 min read
Press Releases
Children’s Hospital Colorado Helps Shape National Standards for Neurodevelopmental and Neurocognitive Care in Sickle Cell Disease
July 28, 2026
·
5 min read
1 of 66,774
Next
